$620 Million is the total value of MFN Partners Management, LP's 15 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 56.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AGN | ALLERGAN PLC | $95,181,000 | +9.5% | 650,101 | 0.0% | 15.35% | +4.1% | |
FOXA | New | FOX CORP | $86,978,000 | – | 2,369,331 | +100.0% | 14.03% | – |
PCG | Buy | PG&E CORP | $71,200,000 | +185.5% | 4,000,000 | +281.0% | 11.48% | +171.4% |
IRWD | IRONWOOD PHARMACEUTICALS INC | $66,832,000 | +30.6% | 4,939,541 | 0.0% | 10.78% | +24.2% | |
LNG | CHENIERE ENERGY INC | $51,270,000 | +15.5% | 750,000 | 0.0% | 8.27% | +9.8% | |
BMY | New | BRISTOL MYERS SQUIBB COcall | $47,710,000 | – | 1,000,000 | +100.0% | 7.70% | – |
XPO | Buy | XPO LOGISTICS INC | $45,437,000 | -4.2% | 845,500 | +1.7% | 7.33% | -8.9% |
GTTN | GTT COMMUNICATIONS INC | $34,700,000 | +46.7% | 1,000,000 | 0.0% | 5.60% | +39.4% | |
GS | GOLDMAN SACHS GROUP INC | $33,370,000 | +14.9% | 173,811 | 0.0% | 5.38% | +9.3% | |
PXD | PIONEER NAT RES CO | $30,456,000 | +15.8% | 200,000 | 0.0% | 4.91% | +10.1% | |
FG | Buy | FGL HLDGS | $23,610,000 | +872.0% | 3,000,000 | +722.7% | 3.81% | +824.3% |
TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $15,990,000 | – | 785,000 | +100.0% | 2.58% | – |
ACRS | ACLARIS THERAPEUTICS INC | $8,985,000 | -18.9% | 1,500,000 | 0.0% | 1.45% | -23.0% | |
NAVI | New | NAVIENT CORPORATION | $7,521,000 | – | 650,000 | +100.0% | 1.21% | – |
RVNC | REVANCE THERAPEUTICS INC | $725,000 | -21.7% | 46,000 | 0.0% | 0.12% | -25.5% | |
SNECQ | Exit | SANCHEZ ENERGY CORP | $0 | – | -1,550,504 | -100.0% | -0.07% | – |
SYF | Exit | SYNCHRONY FINL | $0 | – | -328,022 | -100.0% | -1.31% | – |
AIG | Exit | AMERICAN INTL GROUP INC | $0 | – | -390,000 | -100.0% | -2.61% | – |
ZAYO | Exit | ZAYO GROUP HLDGS INC | $0 | – | -681,818 | -100.0% | -2.64% | – |
FOXA | Exit | TWENTY FIRST CENTY FOX INCcl a | $0 | – | -4,200,000 | -100.0% | -34.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
XPO LOGISTICS INC | 20 | Q3 2023 | 31.8% |
LIBERTY GLOBAL PLC- C | 18 | Q3 2023 | 18.6% |
CYCLERION THERAPEUTICS INC | 16 | Q1 2023 | 2.7% |
HCA HEALTHCARE INC | 15 | Q3 2023 | 10.9% |
CHENIERE ENERGY INC | 13 | Q4 2021 | 19.2% |
OCCIDENTAL PETROLEUM CORP | 13 | Q3 2023 | 10.5% |
PENNYMAC FINL SVCS INC NEW | 11 | Q3 2023 | 12.2% |
ALPHABET INC-CL A | 9 | Q2 2023 | 12.9% |
LITHIA MTRS INC | 8 | Q3 2023 | 16.0% |
META PLATFORMS INC | 7 | Q4 2021 | 14.1% |
View MFN Partners Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Foley Trasimene Acquisition Corp. | March 15, 2021 | 5,000,000 | 4.8% |
Cyclerion Therapeutics, Inc. | February 12, 2021 | 2,427,677 | 7.2% |
Foley Trasimene Acquisition Corp. | February 12, 2021 | 14,000,000 | 13.5% |
Foley Trasimene Acquisition IISold out | February 12, 2021 | 0 | 0.0% |
Aclaris Therapeutics, Inc. | July 22, 2020 | 1,895,677 | 4.5% |
View MFN Partners Management, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-26 |
4 | 2024-04-24 |
4 | 2024-04-19 |
4 | 2024-04-17 |
13F-HR | 2024-02-13 |
4 | 2024-02-12 |
4 | 2024-02-06 |
4 | 2023-11-24 |
4 | 2023-11-20 |
4 | 2023-11-15 |
View MFN Partners Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.